Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Tuesday, November 25, 2014 10:41:25 AM
bullish
good price action
$NTRP recent news/filings
## source: finance.yahoo.com
Fri, 21 Nov 2014 18:04:21 GMT ~ NEUROTROPE, INC. Financials
read full: http://finance.yahoo.com/q/is?s=ntrp
*********************************************************
Thu, 20 Nov 2014 13:30:00 GMT ~ Neurotrope Announces Last Patient Dosed in Phase 2a Clinical Trial of Bryostatin-1 for Alzheimer's Disease
[PR Newswire] - NEWARK, N.J., Nov. 20, 2014 /PRNewswire/ -- Neurotrope, Inc. (OTCQB: NTRP) announced today that the last patient has been dosed in its Phase 2a clinical trial of Bryostatin-1 for the treatment of patients ...
read full: http://finance.yahoo.com/news/neurotrope-announces-last-patient-dosed-133000154.html
*********************************************************
Thu, 13 Nov 2014 21:45:42 GMT ~ NEUROTROPE, INC. Files SEC form 10-Q, Quarterly Report
read full: http://biz.yahoo.com/e/141113/ntrp10-q.html
*********************************************************
Thu, 06 Nov 2014 14:50:59 GMT ~ NEUROTROPE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/141106/ntrp8-k.html
*********************************************************
Thu, 06 Nov 2014 13:30:00 GMT ~ Neurotrope Appoints Warren W. Wasiewski, M.D. as Executive Vice President, Development and Chief Medical Officer
[PR Newswire] - NEWARK, N.J., Nov. 6, 2014 /PRNewswire/ -- Neurotrope, Inc. (NTRP) today announced that Warren W. Wasiewski, M.D., F.A.A.P. has joined Neurotrope BioScience, Inc., the Company's wholly owned operating subsidiary, as its Executive Vice President, Development and Chief Medical Officer, effective immediately. Dr. Wasiewski replaces Dr. Richard Scheyer, who had served as Chief Medical Officer since January 2014.
read full: http://finance.yahoo.com/news/neurotrope-appoints-warren-w-wasiewski-133000199.html
*********************************************************
$NTRP charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$NTRP company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/NTRP/company-info
Ticker: $NTRP
OTC Market Place: OTCQB
CIK code: 0001513856
Company name: Neurotrope, Inc.
Incorporated In: NV, USA
Business Description:
$NTRP share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: 22,868,400 a/o
Par Value: Not Available
$NTRP extra dd links
Company name: Neurotrope, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NTRP+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NTRP+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NTRP+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NTRP/news - http://finance.yahoo.com/q/h?s=NTRP+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NTRP/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NTRP/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NTRP+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NTRP
DTCC (dtcc.com): http://search2.dtcc.com/?q=Neurotrope%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Neurotrope%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Neurotrope%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NTRP
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001513856&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NTRP/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NTRP/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NTRP&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NTRP
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NTRP/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NTRP+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NTRP+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NTRP
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NTRP
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NTRP+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NTRP/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NTRP+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NTRP.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NTRP
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NTRP/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NTRP/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NTRP
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NTRP
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NTRP:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NTRP
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NTRP
$NTRP DD Notes ~ http://www.ddnotesmaker.com/NTRP
Recent SNPX News
- Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Company through its Partnership with Cannasoul Analytics • PR Newswire (US) • 04/09/2024 01:15:00 PM
- Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing • PR Newswire (US) • 04/03/2024 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 03:16:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 10:00:18 PM
- Synaptogenix President Daniel L. Alkon, M.D. Honored for Scientific Presentation at USC-Sponsored Forum on Age-Related Diseases and Neurodegenerative Disorders • PR Newswire (US) • 12/19/2023 02:00:00 PM
- Synaptogenix Joins Leading Neuroscientists and Academics as Speaker at USC-Sponsored Forum on Age-Related Diseases including Alzheimer's • PR Newswire (US) • 12/06/2023 02:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 11/14/2023 10:05:18 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/13/2023 10:00:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 10:00:23 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/03/2023 09:00:19 PM
- Synaptogenix Acquires Significant Stake in Cannasoul Analtyics Ltd. Co-founded by The Technion - Israel Institute of Technology • PR Newswire (US) • 11/02/2023 01:00:00 PM
- Synaptogenix Announces Peer-Reviewed Publication of NIH-Sponsored Phase 2 Clinical Trial Results Demonstrating Safe, Significant, and Persistent Benefits of Bryostatin-1 in Advanced Alzheimer's Disease • PR Newswire (US) • 09/26/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 08:05:55 PM
- Bryostatin-1 from Synaptogenix Shows Statistically Significant Results as an ALS Treatment in Pre-Clinical Independent Study • PR Newswire (US) • 09/07/2023 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:00:40 PM
- Synaptogenix and Cleveland Clinic to Submit Investigational New Drug (IND) Application to FDA for Clinical Trial of Bryostatin-1 in Multiple Sclerosis • PR Newswire (US) • 07/19/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 12:55:57 PM
- Synaptogenix Abstract Highlighting Bryostatin-1 Benefits in Severe Alzheimer's Disease Accepted for Presentation at 11th International Brain Research Organization World Congress of Neuroscience • PR Newswire (US) • 07/13/2023 01:00:00 PM
UC Asset Expected to Report $0.03/share Net Profit for 2023 • UCASU • Apr 11, 2024 10:00 AM
Kona Gold Beverages & Apple Rush Co. Execute Joint Venture & Manufacturing Agreement • APRU • Apr 11, 2024 9:40 AM
VAYK Confirmed Its Eligibility for $1.8 Million Investment through Federal EB5 Program • VAYK • Apr 11, 2024 9:00 AM
ILUS Moves Forward With Its Two Subsidiary Uplists and Equity Dividend • ILUS • Apr 10, 2024 9:36 AM
Quartz Intersects 102m of 2.22 g/t Au and 104 g/t Ag Announces New Discovery at Prodigy on its Maestro Project, British Columbia • QZM • Apr 10, 2024 8:00 AM
Swifty Global Announces Record Annual Results Ahead of National Exchange Reverse Merger • DRCR • Apr 9, 2024 1:55 PM